Glen Eagle Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-250
| Closed | -$538 | – | 1013 |
|
|
2020
Q3 | $538 | Hold |
250
| – | – | ﹤0.01% | 880 |
|
|
2020
Q2 | $290 | Hold |
250
| – | – | ﹤0.01% | 883 |
|
|
2020
Q1 | $230 | Hold |
250
| – | – | ﹤0.01% | 826 |
|
|
2019
Q4 | $395 | Buy |
250
+240
| +2,400% | +$379 | ﹤0.01% | 864 |
|
|
2019
Q3 | $8 | Hold |
10
| – | – | ﹤0.01% | 820 |
|
|
2019
Q2 | $9 | Hold |
10
| – | – | ﹤0.01% | 795 |
|
|
2019
Q1 | $10 | Hold |
10
| – | – | ﹤0.01% | 738 |
|
|
2018
Q4 | $7 | Hold |
10
| – | – | ﹤0.01% | 720 |
|
|
2018
Q3 | $22 | Hold |
10
| – | – | ﹤0.01% | 710 |
|
|
2018
Q2 | $50 | Hold |
10
| – | – | ﹤0.01% | 687 |
|
|
2018
Q1 | $39 | Hold |
10
| – | – | ﹤0.01% | 678 |
|
|
2017
Q4 | $27 | Hold |
10
| – | – | ﹤0.01% | 639 |
|
|
2017
Q3 | $32 | Buy |
+10
| New | +$32 | ﹤0.01% | 632 |
|